Your skin holds vital clues about your health. From thyroid issues to heart problems, discover what your skin is trying to ...

FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs) for use in the first pediatric ...

Encouraging results from our adult rheumatoid arthritis ... fatigue, rash, blurred vision, fever, and appetite changes. Current medical treatment focuses on controlling symptoms.

The positive opinion is based on results from the pivotal Phase 3 SELECT-GCA trial that evaluated the efficacy and safety of upadacitinib ...

Patients treated with baricitinib 4 mg saw significant regrowth of eyebrows and eyelashes at Week 36 compared to placebo Positive data underscore Lilly's continued expansion across dermatologic ...

Monitor patients closely for symptoms and signs that may be clinical manifestations ... Compared with Placebo in Adults with Psoriatic Arthritis Bristol Myers Squibb today announced positive data from ...

Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.

Bristol-Myers Squibb (BMY) stock in focus as psoriasis drug Sotyktu shows promising results in treating psoriatic arthritis ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...